Claris Advisors’s Labcorp LH Stock Holding History

Claris Advisors’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3	Closed	-$670	–	663
2024 Q3	$670	Buy	+3	New	+$659	﹤0.01%	542

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Claris Advisors's LH Position: Q4 2024 in Review

Claris Advisors sold out of Labcorp (LH) in Q4 2024, closing a stake of 3 shares — an estimated $670 sold.

Claris Advisors first reported a position in LH in Q3 2024 and held it in 1 quarter. The position peaked at $670 in Q3 2024. 923 funds tracked by Wall St. Rank hold LH as of Q4 2024.

Claris Advisors reported no remaining Labcorp position as of Q4 2024 after selling out during the quarter.
Claris Advisors sold 3 Labcorp shares in Q4 2024, an estimated $670.
Claris Advisors first reported a position in Labcorp in Q3 2024 and held it in 1 quarter.
Claris Advisors's Labcorp position peaked at $670 in Q3 2024.
923 funds tracked by Wall St. Rank held Labcorp as of Q4 2024.

Based on Claris Advisors's 13F filing for Q4 2024, filed 7 Feb 2025.